Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Massachusetts
Biotech
Pharma's 'urgent need for reinvention': PwC's call to action
PwC has laid out bold ambitions for what it believes drugmakers could achieve by 2035, as well as steps those companies should start taking in 2026.
Fraiser Kansteiner
Jan 8, 2026 6:00am
Former Abiomed CEO launches bid for Massachusetts governor
Oct 1, 2025 4:00pm
Massachusetts most impacted by NIH research cuts: Grant Witness
Sep 18, 2025 9:38am
Fierce Pharma
Massachusetts shed R&D, manufacturing workers in '24: report
Aug 27, 2025 9:34am
Bayer-allied NextRNA Therapeutics winds down operations
Aug 11, 2025 2:30pm
Ono Pharma lays off 83 staffers at Cambridge site
Apr 29, 2025 1:56pm
